These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 33230417)

  • 1. SARS-CoV-2 and
    Iesa MAM; Osman MEM; Hassan MA; Dirar AIA; Abuzeid N; Mancuso JJ; Pandey R; Mohammed AA; Borad MJ; Babiker HM; Konozy EHE
    New Microbes New Infect; 2020 Nov; 38():100817. PubMed ID: 33230417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of Co-inhibitory Receptor Expression in COVID-19 Infection Compared to Acute
    Herrmann M; Schulte S; Wildner NH; Wittner M; Brehm TT; Ramharter M; Woost R; Lohse AW; Jacobs T; Schulze Zur Wiesch J
    Front Immunol; 2020; 11():1870. PubMed ID: 32983106
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Limited Recognition of Highly Conserved Regions of SARS-CoV-2.
    Swaminathan S; Lineburg KE; Ambalathingal GR; Crooks P; Grant EJ; Mohan SV; Raju J; Panikkar A; Le Texier L; Tong ZWM; Chew KY; Neller MA; Short KR; Gowda H; Gras S; Khanna R; Smith C
    Microbiol Spectr; 2022 Feb; 10(1):e0278021. PubMed ID: 35196796
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Revelation of Potent Epitopes Present in Unannotated ORF Antigens of SARS-CoV-2 for Epitope-Based Polyvalent Vaccine Design Using Immunoinformatics Approach.
    Uttamrao PP; Sathyaseelan C; Patro LPP; Rathinavelan T
    Front Immunol; 2021; 12():692937. PubMed ID: 34497604
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insights into
    Indari O; Baral B; Muduli K; Mohanty AP; Swain N; Mohakud NK; Jha HC
    Biosaf Health; 2021 Aug; 3(4):230-234. PubMed ID: 33969285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploring SARS-CoV-2 and
    López-Farfán D; Irigoyen N; Gómez-Díaz E
    Front Immunol; 2023; 14():1120298. PubMed ID: 36993979
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Structural basis of biased T cell receptor recognition of an immunodominant HLA-A2 epitope of the SARS-CoV-2 spike protein.
    Chaurasia P; Nguyen THO; Rowntree LC; Juno JA; Wheatley AK; Kent SJ; Kedzierska K; Rossjohn J; Petersen J
    J Biol Chem; 2021 Sep; 297(3):101065. PubMed ID: 34384783
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD8
    Lineburg KE; Grant EJ; Swaminathan S; Chatzileontiadou DSM; Szeto C; Sloane H; Panikkar A; Raju J; Crooks P; Rehan S; Nguyen AT; Lekieffre L; Neller MA; Tong ZWM; Jayasinghe D; Chew KY; Lobos CA; Halim H; Burrows JM; Riboldi-Tunnicliffe A; Chen W; D'Orsogna L; Khanna R; Short KR; Smith C; Gras S
    Immunity; 2021 May; 54(5):1055-1065.e5. PubMed ID: 33945786
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cellular immune response to SARS-CoV-2 and clinical presentation in individuals exposed to endemic malaria.
    Tapela K; Prah DA; Tetteh B; Nuokpem F; Dosoo D; Coker A; Kumi-Ansah F; Amoako E; Assah KO; Kilba C; Nyakoe N; Quansah D; Languon S; Anyigba CA; Ansah F; Agyeman S; Owusu IA; Schneider K; Ampofo WK; Mutungi JK; Amegatcher G; Aniweh Y; Awandare GA; Quashie PK; Bediako Y
    Cell Rep; 2024 Aug; 43(8):114533. PubMed ID: 39052480
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SARS-CoV-2 genome-wide T cell epitope mapping reveals immunodominance and substantial CD8
    Saini SK; Hersby DS; Tamhane T; Povlsen HR; Amaya Hernandez SP; Nielsen M; Gang AO; Hadrup SR
    Sci Immunol; 2021 Apr; 6(58):. PubMed ID: 33853928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Unbiased Screens Show CD8
    Ferretti AP; Kula T; Wang Y; Nguyen DMV; Weinheimer A; Dunlap GS; Xu Q; Nabilsi N; Perullo CR; Cristofaro AW; Whitton HJ; Virbasius A; Olivier KJ; Buckner LR; Alistar AT; Whitman ED; Bertino SA; Chattopadhyay S; MacBeath G
    Immunity; 2020 Nov; 53(5):1095-1107.e3. PubMed ID: 33128877
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Less Severe Cases of COVID-19 in Sub-Saharan Africa: Could Co-infection or a Recent History of
    Kalungi A; Kinyanda E; Akena DH; Kaleebu P; Bisangwa IM
    Front Immunol; 2021; 12():565625. PubMed ID: 33679730
    [TBL] [Abstract][Full Text] [Related]  

  • 14. T cell epitopes of SARS-CoV-2 spike protein and conserved surface protein of
    Hassan MM; Sharmin S; Hong J; Lee HS; Kim HJ; Hong ST
    Open Life Sci; 2021; 16(1):630-640. PubMed ID: 34222663
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Diverse Humoral Immune Responses in Younger and Older Adult COVID-19 Patients.
    Sasson JM; Campo JJ; Carpenter RM; Young MK; Randall AZ; Trappl-Kimmons K; Oberai A; Hung C; Edgar J; Teng AA; Pablo JV; Liang X; Yee A; Petri WA; Camerini D
    mBio; 2021 Jun; 12(3):e0122921. PubMed ID: 34182775
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antibodies to Cryptic Epitopes in Distant Homologues Underpin a Mechanism of Heterologous Immunity between
    Mitran CJ; Mena A; Gnidehou S; Banman S; Arango E; Lima BAS; Lugo H; Ganesan A; Salanti A; Mbonye AK; Ntumngia F; Barakat K; Adams JH; Kano FS; Carvalho LH; Maestre AE; Good MF; Yanow SK
    mBio; 2019 Oct; 10(5):. PubMed ID: 31594821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunodominant T cell peptides from four candidate malarial antigens as biomarkers of protective immunity against malaria.
    Belmonte M; Ganeshan H; Huang J; Belmonte A; Inoue S; Velasco R; Acheampong N; Ofori EA; Akyea-Mensah K; Frimpong A; Ennuson NA; Frempong AF; Kyei-Baafour E; Amoah LE; Edgel K; Peters B; Villasante E; Kusi KA; Sedegah M
    Vaccine; 2023 Feb; 41(6):1265-1273. PubMed ID: 36642628
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A bioinformatic analysis of T-cell epitope diversity in SARS-CoV-2 variants: association with COVID-19 clinical severity in the United States population.
    Kim GJ; Elnaggar JH; Varnado M; Feehan AK; Tauzier D; Rose R; Lamers SL; Sevalia M; Nicholas N; Gravois E; Fort D; Crabtree JS; Miele L
    Front Immunol; 2024; 15():1357731. PubMed ID: 38784379
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroreactivity of the Severe Acute Respiratory Syndrome Coronavirus 2 Recombinant S Protein, Receptor-Binding Domain, and Its Receptor-Binding Motif in COVID-19 Patients and Their Cross-Reactivity With Pre-COVID-19 Samples From Malaria-Endemic Areas.
    Traoré A; Guindo MA; Konaté D; Traoré B; Diakité SA; Kanté S; Dembélé A; Cissé A; Incandela NC; Kodio M; Coulibaly YI; Faye O; Kajava AV; Pratesi F; Migliorini P; Papini AM; Pacini L; Rovero P; Errante F; Diakité M; Arevalo-Herrera M; Herrera S; Corradin G; Balam S
    Front Immunol; 2022; 13():856033. PubMed ID: 35585976
    [TBL] [Abstract][Full Text] [Related]  

  • 20. COVID-19 coronavirus vaccine T cell epitope prediction analysis based on distributions of HLA class I loci (HLA-A, -B, -C) across global populations.
    Cun Y; Li C; Shi L; Sun M; Dai S; Sun L; Shi L; Yao Y
    Hum Vaccin Immunother; 2021 Apr; 17(4):1097-1108. PubMed ID: 33175614
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.